Literature DB >> 21196776

Effect of antenatal corticosteroid treatment on lung function in full-term newborn infants.

Ola Hjalmarson1, Kenneth L Sandberg.   

Abstract

BACKGROUND: Antenatal treatment of pregnant women with corticosteroids in order to stimulate surfactant production has been shown to be effective. However, lung structure is also affected by the treatment.
OBJECTIVE: We tested the hypothesis that changes within lung acini, induced by maternal corticosteroid treatment, persist during lung development.
METHODS: Twenty-two healthy infants, whose mothers were treated with up to three doses of betamethasone at 25-33 weeks of pregnancy because of preterm labour, but where labour terminated and the infants were born at term, were studied at term and compared to a group of 50 healthy newborn infants without prenatal treatment with corticosteroids. Gas-mixing efficiency was measured in terms of moment ratio with a nitrogen washout method together with functional residual capacity. Mechanical parameters were assessed with the single occlusion technique.
RESULTS: There were no signs of disturbed gas mixing or changed lung volume or mechanics in the treated group.
CONCLUSION: The result contributes to an emerging body of evidence that antenatal treatment with corticosteroids does not permanently affect lung structure or function.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196776     DOI: 10.1159/000320727

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  2 in total

1.  Antenatal corticosteriods decrease forced vital capacity in infants born fullterm.

Authors:  Anuja Bandyopadhyay; James E Slaven; Cindy Evrard; Christina Tiller; David M Haas; Robert S Tepper
Journal:  Pediatr Pulmonol       Date:  2020-07-08

Review 2.  The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.

Authors:  Cindy T McEvoy; Judy L Aschner
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.